Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Analysis of Peripheral Blood Biomarkers for the Prediction and Correlation of Therapeutic Response in Patients with Lung Cancer

Trial Status: administratively complete

This trial analyzes peripheral blood biomarkers for the prediction and correlation of therapeutic response in patients with lung cancer. Peripheral blood contains enormous quantity of biological information that can be potentially used to predict and correlate to treatment response. Analyzing various blood biomarkers in the laboratory, may help doctors decide which treatment is best for different lung cancer patients.

Have a question?
We're here to help

Chat with us: LiveHelp
Call us: 1-800-4-CANCER
(1-800-422-6237)

Which trials are right for you?

Use the checklist in our guide to gather the information you’ll need.